What if a digital twin helped researchers test treatment strategies?
A digital twin is a computer model that is continually updated with data from the real thing it represents. Engineers use them for jet engines and power plants. Researchers now wonder whether similar models of the body, or even of individual patients, could help them test treatment ideas before trying them for real.
⚠ This is a thought experiment. It explores a possibility; it does not report a result.
Original illustration — speculative and artistic, not a depiction of a real device, patient or result.
What exists today
Computer modelling is already part of medicine and medical product development. Models simulate how drugs are absorbed and cleared, how devices interact with tissue, and how diseases spread in populations. The FDA has accepted modelling and simulation as part of the evidence for some products; a well-known example is a simulator of people with type 1 diabetes, which was accepted as a substitute for certain animal testing of insulin-dosing algorithms. True patient-specific digital twins, continuously updated with an individual's data and used to guide their care, are mostly still at the research and pilot stage.
What has been demonstrated
Researchers have built detailed models of organs such as the heart, and of specific processes like blood sugar control, that can reproduce many real-world measurements. Some groups are exploring 'virtual' patients or synthetic control arms, using models or historical data to estimate what might have happened without treatment. A 2023 National Academies report on digital twins concluded that the concept is promising across many fields, including medicine, but identified major research gaps in areas such as validation, uncertainty and data integration. The existence of good models for narrow questions does not mean a whole-body twin of a person is within reach.
What remains difficult
Human biology is enormously complex, and much of it is not fully understood, so any model is a simplification. A twin is only as good as its data, which may be incomplete, noisy or collected at the wrong moments. Models can be very convincing while being wrong in ways that are hard to spot, especially for rare events or patients unlike those in the training data. Validation requires comparing predictions with real outcomes, which takes time. There are also practical issues: privacy of detailed health data, computing costs, and deciding who is responsible if a model-guided decision goes badly.
What would change if it worked
Credible digital twins could let researchers explore many treatment strategies in simulation, then take only the most promising into real trials. That could make trials smaller, faster or better designed, and reduce some animal testing. For individuals, a validated twin might one day help clinicians compare options, such as different drug doses, before choosing one. These models would not replace clinical trials; they would inform which questions to ask. Their value would depend on showing, repeatedly, that predictions match reality closely enough to trust, and on being honest about how uncertain each prediction is.
What evidence would convince us
The key evidence would be prospective validation: using a model to make predictions before outcomes are known, then checking how often it was right, across different patient groups and settings. For clinical use, randomised trials comparing twin-guided decisions with usual care would be the strongest test. Transparent reporting of the model's assumptions, data sources and uncertainty would help others judge and reproduce it. Regulators would need clear standards for when simulation evidence can support or replace experiments. Success on narrow, well-defined questions, repeated over time, would be more convincing than broad claims about simulating an entire person.
Where do you think digital twins could help medicine most?
Polls measure reader opinion for fun and discussion. They are not scientific evidence.
If a computer model predicted that a treatment would not work for you, how much would you want that prediction to count?
Try it hands-on:
Play Drug Development Journey →Related reporting
AI + MedicineWhat If Every Patient Had a Digital Twin? A Thought Experiment About Personalized Medicine
Personalized computer models of the heart and in-silico trials are already used in research and regulation. Scaling them into a living digital twin for every patient raises hard questions of biology, validation and trust.
BreakthroughsInside a Clinical Trial: What Phase 1, 2, and 3 Results Really Mean
A positive Phase 1 result and a positive Phase 3 result sound similar but mean very different things. Here is what each stage of a clinical trial is designed to show, and what it cannot.
AI + MedicineAI Drug Discovery: What Happens Between a Promising Molecule and a Medicine?
AI now helps find drug targets, predict protein shapes and design molecules. But most drugs fail in clinical trials because they don't work well enough or are too toxic, and AI hasn't yet shown it can change that.
